In 1996, Frederic Scheer had a vision when he began to market the concept of compostable plastics. This vision led Cereplast from a pioneer to a leader in the bioplastics industry. Yesterday, the vision of Mr. Scheer and the team at Cereplast provided a breakthrough announcement that will change the face of their industry forever with the transformation of algae into bioplastics.

Cereplast has developed breakthrough technology to transform algae into bioplastics with the intention to launch a new family of algae-based resins that will complement the company’s existing line of Compostables and Hybrid resins.

If successful, Cereplast algae-based resins could replace over 50% of the petroleum content used in plastic resins, possibly having a profound effect on the oil industry. Such companies as Exxon and BP have started to invest money in the algae production business because of the potential in their industry.

Mr. Scheer, who is not only

...

Martek Biosciences (MATK) is up more than 8.5% Friday after the health and nutritional supplements company announced solid fiscal third-quarter results, which included a bump in its 2008 guidance.

Earnings per share reached 28 cents in the quarter, which topped the consensus by more than 16%. Last year, the company earned 19 cents in the same quarter. Revenues advanced 14% to $88.4 million from $77.8 million. MATK was bolstered by its core infant formula business.

MATK now expects earnings per share between $1.06 and $1.09 for the full fiscal year, which is up from its previous guidance and would mark a significant advance of year-ago levels.

MATK is a Zacks #3 Rank company with earnings estimates that have been steady over the past 2 months. However, that could change in the near future as analysts pour over its quarterly report and guidance.

"MATK" Free Stock ...